SAMSUNG Bioepis said yesterday that it plans to soon start phase 1 clinical trials for its first new drug candidate in development with Japan’s Takeda Pharmaceutical, setting a fresh milestone in the South Korean drugmaker’s push into new drug development.

AIMING to seize opportunities from the growing global popularity of electric vehicles, Samsung SDI has confirmed it will proceed with a plan to supply batteries for BMW’s upcoming EV i3 model in China.